Exodus Point Capital Management, LP Applied Genetic Technologies Corp Transaction History

Exodus Point Capital Management, LP

  • $14.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$1.87 - $2.91 $36,420 - $56,675
-19,476 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$3.01 - $4.12 $176,057 - $240,982
-58,491 Reduced 75.02%
19,476 $59,000
Q2 2021

Aug 16, 2021
BUY
$3.62 - $5.23 $199,842 - $288,722
55,205 Added 242.53%
77,967 $305,000
Q1 2021

May 17, 2021
BUY
$3.94 - $8.19 $89,682 - $186,420
22,762 New
22,762 $115,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email